← Leaderboards
Feiyan Mo
Baylor College Of Medicine
$440,965
Attributed
$440,965
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $97.3K · FY2020–25$100K$75K$50K$25K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$440,965 · 2
By mechanism
K00$347,909 · 1
F99$93,056 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Helen E Heslop$25,308,937
- Cliona M Rooney$13,445,584
- Malcolm K Brenner$13,204,649
- Hugo J Bellen$42,403,967
- David John Tweardy$14,168,425
Others in their field
Other Emerging Leaders on “Exhaust”
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,215,638
- Lynn Briscoe · Leidos Biomedical Research, Inc.$15,054,787
- Crystal Mackall · Children'S Hosp Of Philadelphia$15,003,117
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$11,360,163
- Shannon Jackson · Leidos Biomedical Research, Inc.$9,812,993
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$8,254,717
Research focus
ExhaustAdoptive Cell TransfersEngineeringEvaluationAllogenicAntibodiesCytokineAdoptive TransferAffectCancer TherapyCar T Cell TherapyCd19 GeneCellsCell TherapyAutologousChemokineChimeric Antigen ReceptorChimeric Antigen Receptor T CellsCancer PatientClinical ResearchClinical TranslationComplexCostGenetic
Grant awards (6)
Improving the Efficacy of Allogeneic Cell Therapies of Cancer$97,330
K00 · FY2025 · CA · contact PI
Improving the Efficacy of Allogeneic Cell Therapies of Cancer$97,330
K00 · FY2024 · CA · contact PI
Improving the Efficacy of Allogeneic Cell Therapies of Cancer$77,757
K00 · FY2023 · CA · contact PI
Improving the Efficacy of Allogeneic Cell Therapies of Cancer$75,492
K00 · FY2022 · CA · contact PI
Improving the Efficacy of Allogeneic Cell Therapies of Cancer$46,036
F99 · FY2021 · CA · contact PI
Improving the Efficacy of Allogeneic Cell Therapies of Cancer$47,020
F99 · FY2020 · CA · contact PI